Trial Profile
The Influence of Peripheral Androgen Conversion at Toll-like Receptors-2 and CD1d Expressions in Human Keratinocytes as Well as Their Modulation After 6 Months Treatment With Oral Contraceptive.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Azelaic acid
- Indications Acne vulgaris
- Focus Biomarker; Therapeutic Use
- 19 Aug 2013 New source identified and integrated (Brazilian Clinical Trials Registry: RBR7ddb5s)
- 20 May 2013 New trial record